Search - tctmd.com

Displaying 41 - 60 of 243

Sort: Relevancy | Date

News Daily News

‘Hey, ChatGPT: Surgery or the Cath Lab?’ Study Shows AI Can Aid Decision-Making

Yael L. Maxwell

August 14, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Daily News

PCI Complications Portend Dire Outcomes: Tracking Could Be Key

Caitlin E. Cox

July 25, 2024

News Features

Valvular Heart Disease Has a Diversity Problem

Yael L. Maxwell

July 12, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

Shelley Wood

May 31, 2024

News Conference News SCAI 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

L.A. McKeown

May 06, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Conference News ACC 2024

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Caitlin E. Cox

April 07, 2024

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

News Conference News CRT 2024

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

L.A. McKeown

March 15, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

L.A. McKeown

March 01, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

L.A. McKeown

January 19, 2024

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Conference News TCT 2023

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

Todd Neale

October 23, 2023

Advertisement

‘Hey, ChatGPT: Surgery or the Cath Lab?’ Study Shows AI Can Aid Decision-Making

DES Best for In-Stent Restenosis, but DCBs Also Viable

PCI Complications Portend Dire Outcomes: Tracking Could Be Key

Valvular Heart Disease Has a Diversity Problem

TCTMD’s Top 10 Most Popular Stories for May 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

May 2024 Dispatch for the CV Team

FDA Approves Bioresorbable Scaffold for BTK Lesions

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

March 2024 Dispatch for the CV Team

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content